The current valuation score of Dynavax Technologies Corp is 7.94, ranking 73 out of 391 in the Biotechnology & Medical Research industry. Its current P/E ratio is -42.61, which is -501.11% below the recent high of 170.92 and -608.32% above the recent low of -301.83.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.